4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001713070-26-000002
Director sold 5,740 shares at $25.12 ($144,189)
- Director acquired 7,751 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
SULIMAN SHEHNAAZ · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-14 | Grant or award : show line 1 in the form 10b5-1 | +7,751 | 33,691 | D | ||
| 2026-05-18 | Sale : show line 2 in the form 10b5-1 | −5,740 | $25.12 | $144,189 | 27,951 | D |
| Open-market sales · 5,740 sh · avg $25.12 · $144,189 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-14 | Grant or award : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | +14,058 | 14,058 | D |
Loading xslF345X06/ownership.xml…